# Blocking receptor signals can help treat fibrosis

Source: [Medical Xpress - latest medical and health news stories](https://medicalxpress.com/news/2026-11-blocking-receptor-fibrosis.html) · 2026-11-19 · Medicine
Page: https://themorning.science/story/blocking-receptor-signals-can-help-treat-fibrosis-72b96e349d80f67f
Kind: research · Impact: medium

## In brief

- An investigator-initiated trial showed that inhibiting the cytokines IL-4 and IL-13 can prevent fibrosis in localized scleroderma, a skin disease.
- The researchers suggest the findings could pave the way for preventing and treating other fibrotic conditions.
- The source summary is brief and does not give trial size, dosing, or detailed results.

## Why it matters

The result points to IL-4 and IL-13 signalling as a possible target for stopping fibrosis, a process relevant to many diseases beyond localized scleroderma.

## Timeline

- 2026-11-19: Medical Xpress reported the investigator-initiated trial results on blocking IL-4 and IL-13 in localized scleroderma

## Coverage

- [Blocking receptor signals can help treat fibrosis](https://medicalxpress.com/news/2026-11-blocking-receptor-fibrosis.html) — Medical Xpress - latest medical and health news stories, 2026-11-19

Tags: fibrosis, localized scleroderma, il-4, il-13, cytokines, clinical trial

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
